OSSIAM BLOOMBERG EUROPE ex EUROZONE PAB NR 1C
OSSIAM BLOOMBERG EUROPE ex EUROZONE PAB NR 1C Kurs - 1 Jahr
Baader Bank gettex Düsseldorf Lang & Schwarz München Stuttgart Tradegate XETRA QuotrixWichtige Stammdaten
Emittent | OSSIAM |
Auflagedatum | 10.11.2017 |
Kategorie | Aktien |
Fondswährung | EUR |
Benchmark | |
Ausschüttungsart | Thesaurierend |
Total Expense Ratio (TER) | 0,17 % |
Fondsgröße | 291.067.658,89 |
Replikationsart | Physisch vollständig |
Morningstar Rating | - |
Anlageziel OSSIAM BLOOMBERG EUROPE ex EUROZONE PAB NR 1C EUR
So investiert der OSSIAM BLOOMBERG EUROPE ex EUROZONE PAB NR 1C EUR: The investment objective of the Fund is to replicate, before the Fund's fees and expenses, the performance of the Bloomberg PAB Europe DM ex Eurozone Large & Mid Cap Net Return Index (the “Index”, ticker: EUXPABNL) closing level. The Fund is a financial product that pursuant to Article 9(3) of Regulation (EU) 2019/2088 of the European Parliament and of the Council of 27 November 2019 on sustainability-related disclosures in the financial services sector (the “SFDR”) has the objective of reducing carbon emissions in view of achieving the long-term global warming objectives of the Paris Agreement through the replication of the Index. The Index is a Bloomberg Global Equity Paris-Aligned Index expressed in EUR, calculated and published by Bloomberg (the "Index Provider"). The anticipated level of tracking error in normal conditions is 1.00% over a one-year period.
Der OSSIAM BLOOMBERG EUROPE ex EUROZONE PAB NR 1C EUR gehört zur Kategorie "Aktien".
Wertentwicklung (NAV) WKN: A2DVG2
3 Monate | 6 Monate | 1 Jahr | 3 Jahre | 5 Jahre | 2025 | |
---|---|---|---|---|---|---|
Performance | -4,55 % | -8,29 % | -0,27 % | +5,83 % | +57,10 % | -5,50 % |
Outperformance ggü. Kategorie | -0,31 % | -2,08 % | +0,52 % | +0,51 % | +10,13 % | +0,64 % |
Max Verlust | - | - | -10,98 % | -22,88 % | -25,57 % | - |
Kurs | - | - | - | - | - | 156,54 € |
Hoch | - | - | 177,04 € | - | - | - |
Tief | - | - | 150,34 € | - | - | - |
Kennzahlen ISIN: LU1655103486
Name | 1 Jahr | 3 Jahre | 5 Jahre | 10 Jahre |
---|---|---|---|---|
Volatilität | 11,40 % | 13,48 % | 12,89 % | |
Sharpe Ratio | +0,39 | +0,30 | +0,85 |
Zusammensetzung WKN: A2DVG2
Größte Positionen ISIN: LU1655103486
Name | ISIN | Marktkapitalisierung | Gewichtung |
---|---|---|---|
Novo Nordisk AS Class B | DK0062498333 | 259.143.055.979 € | 5,79 % |
Nestle SA | CH0038863350 | 238.513.055.170 € | 4,79 % |
AstraZeneca PLC | GB0009895292 | 186.204.309.984 € | 4,66 % |
Novartis AG Registered Shares | CH0012005267 | 181.553.787.993 € | 4,66 % |
Roche Holding AG | CH0012032048 | 215.851.677.026 € | 4,37 % |
HSBC Holdings PLC | GB0005405286 | 158.587.065.045 € | 3,86 % |
Unilever PLC | GB00B10RZP78 | 215.899.946.155 € | 3,12 % |
RELX PLC | GB00B2B0DG97 | 81.105.498.110 € | 2,19 % |
Compagnie Financiere Richemont SA Class A | CH0210483332 | 86.459.970.156 € | 1,99 % |
Zurich Insurance Group AG | CH0011075394 | 82.840.155.235 € | 1,91 % |
Summe Top 10 | 37,33 % |
Weitere ETFs mit gleicher Benchmark
ETF | TER | Größe | Perf 1J |
---|---|---|---|
OSSIAM BLOOMBERG EUROPE ex EUROZONE PAB NR 1C EUR | 0,17 % | 291,07 Mio. € | -0,27 % |
iShares MSCI USA ESG Enhanced CTB UCITS ETF EUR Hedged Acc | 0,10 % | 17,33 Mrd. € | +3,07 % |
Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C | 0,10 % | 16,63 Mrd. € | +3,39 % |
Amundi Index Solutions - Amundi EURO Corporates UCITS ETF DR EUR C | 0,14 % | 6,25 Mrd. € | +4,08 % |
Amundi S&P 500 Screened UCITS ETF - Acc | 0,12 % | 4,93 Mrd. € | -2,09 % |